Medical Director at The Rare Care Centre, Perth Children’s Hospital, Australia
Clinical Professor Gareth Baynam is a globally recognized leader in rare diseases, precision public health, and equitable healthcare innovation. With over two decades of experience as a clinical geneticist and translational scientist, he holds numerous influential roles across academia, healthcare policy, and genomics research, including Director of the Undiagnosed Diseases Network International and Medical Director of the Rare Care Centre in Western Australia. His work focuses on advancing health equity, particularly for children, Indigenous populations, and those with rare diseases. Gareth has pioneered several international collaborations and state-wide initiatives, transforming research into sustainable clinical applications. His influential publications and numerous accolades, including the Western Australia Minister for Health’s Award and recognition from the Genetic and Rare Diseases Network, underscore his profound impact on healthcare systems and patient communities. His innovative, inclusive, and patient-centered approach makes him a strong and highly suitable candidate for the Best Researcher Award.
Professional Profile
Education🎓
Professor Gareth Baynam possesses an impressive and multidisciplinary educational background that underpins his impactful career in clinical genetics and public health innovation. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Western Australia in 1997, followed by a Diploma in Child Health (DCH) in 1999. He earned his Fellowship from the Royal Australasian College of Physicians (FRACP) in 2001, specializing in Medicine. Driven by a passion for translational research, he completed a Ph.D. in Vaccine Genetics at the University of Western Australia in 2008, further strengthening his foundation in genomic science. In 2020, he also became an Associate Fellow of the Australasian Institute of Digital Health (A/FAIDH), reflecting his commitment to health informatics and digital health transformation. His comprehensive education equips him with the clinical, scientific, and technological expertise necessary to lead innovative healthcare initiatives and influence global health policies, particularly in rare disease research and precision medicine.
Professional Experience📝
Professor Gareth Baynam has a distinguished professional career that spans clinical practice, academic leadership, health policy, and global research collaboration. Since 2008, he has served as a Clinical Geneticist at Genetic Services of Western Australia, where he provides expert care and contributes to advancing genetic medicine. He held the position of Raine Clinician Research Fellow from 2014 to 2019, a prestigious role that allowed him to bridge clinical service with impactful research. He has served as a Clinical Associate Professor and later Clinical Professor at the University of Western Australia, and also holds academic appointments at Curtin University, the University of Notre Dame, and serves on multiple national and international advisory boards. As Medical Director of the Rare Care Centre and Director of the Undiagnosed Diseases Network International, he leads innovative initiatives in rare disease diagnosis and care. His professional journey is marked by a deep commitment to equitable healthcare and translational genomics.
Research Interest🔎
Professor Gareth Baynam’s research interests lie at the intersection of clinical genetics, precision public health, and equitable healthcare delivery. He is particularly passionate about improving outcomes for individuals with rare diseases, birth defects, and cerebral palsy, with a strong focus on Indigenous and underserved communities. His work emphasizes the use of innovative technologies—ranging from ancient knowledge systems to modern genomics and digital health—to develop sustainable, patient-centered healthcare solutions. He is a pioneer in translational science, transforming cutting-edge research into real-world clinical applications through deep community engagement and multi-sector partnerships. Professor Baynam also plays a critical role in shaping health policy and genomic strategies at national and global levels. His efforts support the integration of precision medicine into primary care systems and promote health equity through public-private partnerships. Ultimately, his research is driven by a commitment to ensuring that scientific advances reach those most in need, creating a global impact in rare disease care.
Award and Honor🏆
Professor Gareth Baynam has received numerous prestigious awards and honors in recognition of his exceptional contributions to healthcare, research, and innovation. In 2019, he was awarded the Western Australia Minister for Health’s Award—the highest accolade in the WA Health System—for his significant and sustainable impact on population-scale health innovations, particularly benefiting children, youth with rare diseases, and Aboriginal communities. In 2018, he was bestowed with the first Honorary Lifetime Membership of the Genetic and Rare Diseases Network WA (GaRDN), honoring his tireless dedication and collaborative efforts to improve the lives of those affected by genetic and rare diseases. He was also a finalist in the 2019 Premier’s Science Awards, reflecting his prominence in scientific advancement. More recently, in 2024, he was named a finalist for both the Channel 7 Child Health Hero and the NMHS NAIDOC Award, further highlighting his continued excellence in child health advocacy and Indigenous health initiatives.
Research Skill🔬
Professor Gareth Baynam possesses a comprehensive and impactful set of research skills that span clinical genetics, public health, policy development, and translational science. He excels in designing and implementing research frameworks that bridge the gap between cutting-edge science and real-world healthcare delivery, particularly in the context of rare diseases and underserved populations. His skills include leading multi-disciplinary, cross-sectoral collaborations and translating complex genomic research into accessible clinical applications. He is adept in data-driven innovation, combining modern informatics with traditional and community-based knowledge to address health disparities. Professor Baynam demonstrates exceptional ability in stakeholder engagement, having successfully coordinated national and international initiatives involving governments, NGOs, industry partners, and Indigenous communities. He also contributes to health system reforms through policy advising, guideline development, and capacity-building. His research leadership has not only advanced scientific understanding but also ensured that innovations lead to tangible, sustainable improvements in patient care and health equity globally.
Conclusion💡
Professor Gareth Baynam stands out as an exemplary candidate for the Best Researcher Award due to his:
-
Leadership in global health and rare disease research.
-
Multidisciplinary and international contributions.
-
Commitment to equitable, inclusive, and translational science.
-
Recognized excellence through prestigious awards and global collaborations.
He not only meets but exceeds the typical criteria expected for this award. With minor enhancements in showcasing commercialization potential and international collaborations (esp. with Singapore), his profile could serve as a benchmark for impactful, socially conscious scientific leadership.
Publications Top Noted✍️
-
Title: The human phenotype ontology in 2021
Authors: S Köhler, M Gargano, N Matentzoglu, LC Carmody, D Lewis-Smith, et al.
Year: 2021
Citations: 901
-
Title: Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
Authors: S Köhler, L Carmody, N Vasilevsky, JOB Jacobsen, D Danis, JP Gourdine, et al.
Year: 2019
Citations: 743
-
Title: The human phenotype ontology in 2017
Authors: S Köhler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Aymé, et al.
Year: 2017
Citations: 653
-
Title: How many rare diseases are there?
Authors: M Haendel, N Vasilevsky, D Unni, C Bologa, N Harris, H Rehm, et al.
Year: 2020
Citations: 464
-
Title: International cooperation to enable the diagnosis of all rare genetic diseases
Authors: KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, et al.
Year: 2017
Citations: 447
-
Title: The human phenotype ontology in 2017
Authors: S Kohler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Ayme, et al.
Year: 2017
Citations: 383
-
Title: Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections
Authors: AM Bertoli-Avella, E Gillis, H Morisaki, JMA Verhagen, BM De Graaf, et al.
Year: 2015
Citations: 341
-
Title: Modeling 3D facial shape from DNA
Authors: P Claes, DK Liberton, K Daniels, KM Rosana, EE Quillen, LN Pearson, et al.
Year: 2014
Citations: 335
-
Title: X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
Authors: H Hu, SA Haas, J Chelly, H Van Esch, M Raynaud, APM de Brouwer, et al.
Year: 2016
Citations: 330
-
Title: Rights, interests and expectations: Indigenous perspectives on unrestricted access to genomic data
Authors: M Hudson, NA Garrison, R Sterling, NR Caron, K Fox, J Yracheta, et al.
Year: 2020
Citations: 255
-
Title: Future of rare diseases research 2017–2027: an IRDiRC perspective
Authors: CP Austin, CM Cutillo, LPL Lau, AH Jonker, A Rath, D Julkowska, et al.
Year: 2017
Citations: 255
-
Title: The human phenotype ontology: semantic unification of common and rare disease
Authors: T Groza, S Köhler, D Moldenhauer, N Vasilevsky, G Baynam, T Zemojtel, et al.
Year: 2015
Citations: 240
-
Title: Extending the phenotypes associated with DICER1 mutations
Authors: WD Foulkes, A Bahubeshi, N Hamel, B Pasini, S Asioli, G Baynam, et al.
Year: 2011
Citations: 215
-
Title: Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X‐Linked Kabuki Syndrome Subtype 2
Authors: N Bögershausen, V Gatinois, V Riehmer, H Kayserili, J Becker, et al.
Year: 2016
Citations: 197
